Commenting on the Federal Court of Altamira ruling, Ms. Ayesha Hira, Interim President and CEO of Belo Sun, said, "We look forward to working with INCRA on the next steps following the ruling by the ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Hamilton, Bermuda, Oct. 04, 2024 (GLOBE NEWSWIRE) -- Altamira Therapeutics Ltd. (“Altamira” or the “Company”) (Nasdaq:CYTO) today announced that it received on September 30, 2024 ...

SAN DIEGO--(BUSINESS WIRE)--Valora Therapeutics Inc. (“Valora”), a biotechnology company pioneering a novel approach to immunotherapy, today announced the successful closing of its seed funding round.

Viking Therapeutics has a lot of momentum going into 2025. Its lead candidate appears to be performing well in aiding weight loss. It also has a couple of interesting other programs in its pipeline.

The deal has secured Novartis the chance to work with Ratio Therapeutics on a novel drug candidate that could fortify the Big Pharma against competition from would-be radiopharmaceutical rivals such ...

HAMILTON, Bermuda - Nuance Pharma has extended its exclusive license and distribution agreement with Altamira Medica Ltd. to include seven additional countries in East and South ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Investing.com – U.S. equities were mixed at the close on Friday, as gains in the Healthcare, Technology and Consumer Goods sectors propelled shares higher while losses in the... Investing.com – U.S.